KRYS - Krystal Biotech GAAP EPS of -$1.25 misses by $0.51 August, 07 2023 07:18 AM Krystal Biotech Inc. 2023-08-07 07:18:11 ET Krystal Biotech press release ( NASDAQ: KRYS ): Q2 GAAP EPS of -$1.25 misses by $0.51 . Cash, cash equivalents, and investments totaled $505.9 million on June 30, 2023. For further details see: Krystal Biotech GAAP EPS of -$1.25 misses by $0.51